PubRank

J P Wietze van der Veen

Author PubWeight™ 13.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet 2012 1.81
2 Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 2009 1.56
3 Formation of fibrosis after nonablative and ablative fractional laser therapy. Dermatol Surg 2011 1.41
4 The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol 2009 1.07
5 Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study. J Am Acad Dermatol 2011 0.90
6 Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PLoS One 2010 0.88
7 High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo. Horm Res Paediatr 2013 0.83
8 Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study. Lasers Surg Med 2010 0.82
9 Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study. J Dermatolog Treat 2011 0.82
10 Ablative fractional laser therapy as treatment for Becker nevus: a randomized controlled pilot study. J Am Acad Dermatol 2011 0.79
11 Hypertrophy in port-wine stains: prevalence and patient characteristics in a large patient cohort. J Am Acad Dermatol 2012 0.79
12 Characteristics of patients with universal vitiligo and health-related quality of life. Arch Dermatol 2008 0.77
13 The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo. Pigment Cell Melanoma Res 2014 0.77
14 Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo. J Eur Acad Dermatol Venereol 2012 0.76